Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2024
Primary Central Nervous System Lymphoma Tumor Biopsies Show Heterogeneity in Gene Expression Profiles, Genetic Subtypes, and in vitro Drug Sensitivity to Kinase Inhibitors
Yuan Xiao Zhu, Jasper Ch Wong, Talal Hilal, et al.
Leukemia & Lymphoma
|
May 27, 2020
Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816
Chul S Ha, Michael LeBlanc, Heiko Schöder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2018
Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus <sup>131</sup>I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016
Mazyar Shadman, Hongli Li, Lisa Rimsza, et al.
Blood
|
September 21, 2007
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma
Ken H Young, Dennis D Weisenburger, Bhavana J Dave, et al.
Biopreservation and Biobanking
|
August 8, 2025
Advancing HIV and Cancer Research: Implementing an AIDS and Cancer Specimen Resource in Latin America
Larissa L S Scholte, Evandro S Mello, Karim Yaqub Ibrahim, et al.
Haematologica
|
May 7, 2011
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy
Teresa M Cardesa-Salzmann, Luis Colomo, Gonzalo Gutierrez, et al.
Cancer Cell
|
April 13, 2016
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma
Yibin Yang, Priscilla Kelly, Arthur L Shaffer, et al.
Blood
|
May 14, 2011
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project
Jan Delabie, Harald Holte, Julie M Vose, et al.
British Journal of Haematology
|
October 26, 2023
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab
Colleen A Ramsower, Allison Rosenthal, Ryan S Robetorye, et al.
Haematologica
|
November 3, 2009
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
Ana Mozos, Cristina Royo, Elena Hartmann, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Medrxiv : the Preprint Server for Health Sciences
|
December 16, 2024
Primary Central Nervous System Lymphoma Tumor Biopsies Show Heterogeneity in Gene Expression Profiles, Genetic Subtypes, and in vitro Drug Sensitivity to Kinase Inhibitors
Yuan Xiao Zhu, Jasper Ch Wong, Talal Hilal, et al.
Leukemia & Lymphoma
|
May 27, 2020
Potential impact of consolidation radiation therapy for advanced Hodgkin lymphoma: a secondary analysis of SWOG S0816
Chul S Ha, Michael LeBlanc, Heiko Schöder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2018
Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus <sup>131</sup>I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016
Mazyar Shadman, Hongli Li, Lisa Rimsza, et al.
Blood
|
September 21, 2007
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma
Ken H Young, Dennis D Weisenburger, Bhavana J Dave, et al.
Biopreservation and Biobanking
|
August 8, 2025
Advancing HIV and Cancer Research: Implementing an AIDS and Cancer Specimen Resource in Latin America
Larissa L S Scholte, Evandro S Mello, Karim Yaqub Ibrahim, et al.
Haematologica
|
May 7, 2011
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy
Teresa M Cardesa-Salzmann, Luis Colomo, Gonzalo Gutierrez, et al.
Cancer Cell
|
April 13, 2016
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma
Yibin Yang, Priscilla Kelly, Arthur L Shaffer, et al.
Blood
|
May 14, 2011
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project
Jan Delabie, Harald Holte, Julie M Vose, et al.
British Journal of Haematology
|
October 26, 2023
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab
Colleen A Ramsower, Allison Rosenthal, Ryan S Robetorye, et al.
Haematologica
|
November 3, 2009
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype
Ana Mozos, Cristina Royo, Elena Hartmann, et al.
Page
of 6